The XVIII Riunione Stabiese di Epatologia will take place on 13–14 November 2026 at the Hotel degli Ulivi in Gragnano, with diabetes, obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) as central themes.
The meeting marks the 18th edition of the event and 25 years of activity. The 2026 programme includes seven scientific sessions, keynote lectures and contributions from specialists and researchers from Italian and international centres.
Friday's programme focuses on clinical hepatology and hepatitis B, C and D, including efforts to identify patients who remain undiagnosed. Saturday's programme addresses new treatments for liver cancer and the use of artificial intelligence in hepatology.
Alessio Fasano is scheduled to give a lecture on the relationship between microbiota, diet and behaviour in obesity.
Carmine Coppola describes the meeting as part of a 25-year path reflecting major changes in hepatology and the growing importance of metabolic diseases and new therapies.
Complete session times, the full list of speakers and registration details were not included in the reports available ahead of the meeting.
